mioID ONE
Smart NFC + QR wearable that creates a secure, portable digital health identity.
An operational, revenue-generating healthcare platform at the intersection of eight markets worth $7.2T+. 300K+ devices deployed, 20K+ active users — now raising €1M to scale across Europe and beyond.
Meet mioID ONE — a medical-grade wearable that carries your encrypted health identity, monitors your vitals around the clock, and puts AI-guided care one tap away. Your whole health, in one place.
Operational business · 9 live partner projects · trademarks registered.
GDPR-ready · HIPAA-aligned · AES-256 encrypted — your data, your identity.
Five revenue-generating products, one connected ecosystem. ID LIFE links portable health identity, clinical AI and point-of-care diagnostics into a platform that scales horizontally across markets — building a defensible position in each of them.
Five products, one connected ecosystem — your identity, your vitals, your care, all in one place. Each works beautifully on its own, and even better together: a single, private health layer that follows you wherever life takes you.
Six interconnected components that operate on their own — or together as one continuous layer from device to clinician.
Smart NFC + QR wearable that creates a secure, portable digital health identity.
Healthcare-grade AI turning identity data and vitals into clinical insight.
Distributed point-of-care testing network integrated with the identity layer.
Continuous residential monitoring with smart sensors and AI-driven alerts.
Secure video consultations connecting patients to licensed professionals.
A unified dashboard aggregating every stream across the platform.
mioID ONE stores encrypted health identity on a medical-grade NFC/QR wearable, with AES-256 encryption and instant emergency data access.
A healthcare LLM for clinical triage, symptom analysis, drug-interaction alerts and risk scoring — turning raw signals into guidance you can act on.
A distributed point-of-care network linking devices, labs and mobile units directly to the identity layer for fast, traceable results.
Each product is a business on its own — and far more powerful connected.
A medical-grade NFC + QR device storing encrypted personal health identity, with emergency data access and global interoperability.
A proprietary LLM trained on healthcare data, processing identity and vitals into clinical insight at population scale.
A distributed point-of-care network linking devices and labs with instant result attribution and real-time physician routing.
Smart home sensors, wearables and AI oversight enabling continuous care without hospitalization — a hospital-at-home alternative.
Medical-grade smartwatch and ring capturing continuous biometric data that streams straight into SalusGPT.
ATTILIO combines ambient sensors, wearables and AI oversight to keep watch at home — continuous, passive monitoring that flags what matters and stays quiet when all is well. No appointments, no effort, just peace of mind.
The MYO Watch and ATTILIO Ring capture continuous, medical-grade biometric data — heart rate, oxygen, temperature and activity — streamed straight to your identity layer so your full picture is always one tap away.
No clinics, no complexity — just wear it and let the ecosystem do the work.
Slip on mioID ONE. Your encrypted health identity now lives on your wrist — ready when you need it.
The MYO Watch and ATTILIO Ring track heart rate, oxygen, temperature, sleep and activity — continuously.
SalusGPT turns your data into clear guidance, alerts and risk scores — in plain language you actually understand.
Tap to share with any clinician, book a telemedicine visit, or grant first responders instant emergency access.
One identity, always-on monitoring, AI guidance and total privacy — the everyday benefits of a connected health layer.
Your health record in your pocket — recognised across providers, pharmacies, airports and emergency rooms.
Continuous monitoring that quietly watches your vitals and flags what matters — before it becomes a problem.
SalusGPT explains symptoms, checks your medications for interactions and scores your risks — in plain words.
Telemedicine and ATTILIO home monitoring bring care to you — fewer appointments, no commutes, less stress.
First responders get the data they need in seconds — even when you can't speak for yourself.
AES-256 encrypted and GDPR-ready. Nothing is shared without your explicit consent — ever.
A $7.2T+ total addressable market across the sectors ID LIFE sits at the intersection of.
AI in healthcare is the fastest-growing segment in all of technology, at +48% CAGR.
ID LIFE is not a concept — it's an operational business with measurable traction and validated market fit.
Real projects. Real partners. Real-world validation.
LLMs have reached clinical capability — enabling scalable intelligent health services for the first time in history (2024–2026).
1.4 billion people will be over 60 by 2030, driving demand for remote monitoring and preventive care.
Hospital-at-home models are now reimbursed in 34 countries — providers need a platform to deploy.
A 10-million healthcare worker shortfall by 2030 makes AI-assisted triage and automated monitoring essential.
The EU Digital Identity Act and global regulations mandate interoperable digital health identity frameworks.
Payers are moving reimbursement from treatment to prevention, favouring continuous monitoring platforms.
A round structured to scale a validated, operational platform across eight converging markets.
A clear path from validated platform to category leader — this round funds the next two steps.
Forward-looking targets shown for illustration — full projections in the investor deck.
Unified patient identity, remote monitoring, AI diagnostic support and outcome analytics.
Screening continuity, patient engagement, population health analytics and data infrastructure.
Risk stratification, preventive programs, fraud reduction and dynamic pricing.
Employee wellness, population health, telemedicine access and engagement analytics.
Guest health services, on-site diagnostics, medical concierge and health certification.
Health verification, identity-linked status, rapid triage and compliance tools.
Population monitoring, emergency response, public health data and city-scale operations.
Turn one-off campaigns into long-term, connected healthcare journeys.
Full EU compliance with data minimization and consent management.
AES-256 encryption, ISO 27001 alignment and multi-region redundancy.
HIPAA alignment with pseudonymization and data classification.
HL7 FHIR, DICOM and CE-marked medical device standards.
ID LIFE is a healthcare infrastructure platform that unifies wearable identity, AI diagnostics, telemedicine and health-data systems. Each component — mioID ONE, SalusGPT, Apollo Diagnostics and ATTILIO — works on its own or as one integrated layer for global healthcare delivery.
Identity is stored with AES-256 encryption on your mioID ONE device. The platform is GDPR-ready, HIPAA-aligned and built to ISO 27001 standards, with HL7 FHIR and DICOM support and CE-marked device integrations — emergency data is accessible when it counts, private otherwise.
SalusGPT is a clinical-grade AI engine. It provides triage, symptom analysis, drug-interaction alerts and personalised risk scoring — translating continuous data from your wearables into clear, actionable health guidance.
Healthcare providers, pharmaceutical companies, insurers, corporate and public welfare programs, hospitality, airports and travel, municipalities and large-scale screening programs — anywhere portable identity and continuous monitoring create value.
Request yours through the contact form and we'll guide you through activation. Setup takes minutes: pair the device, create your encrypted identity, and you're monitored from day one. This is a demo, so submissions are simulated and stored only in your browser.
No. ID LIFE works on its own — monitoring your vitals and giving you AI-guided insight from SalusGPT. When you do want a professional, you can share your data with any clinician in one tap or book a telemedicine visit directly.
A strategic growth round is open at a €6M post-money valuation, with a €1M round size for 16.7% equity. Funds are allocated across product development (35%), commercial expansion (30%), regulatory & compliance (20%) and operations & team (15%).
Reach out through the Contact form and our team in Milano, Lugano or London will follow up with the investor deck and partnership details. This is a demo — submissions are simulated and stored only in your browser.
Whether you're a provider, partner or investor — let's talk about what ID LIFE can do for you.